Intervet/Schering-Plough Animal Health announced that its new Innovax poultry vaccine range has been introduced in markets in Latin America.
The Innovax range consists of live virus vector vaccines that protect against pathogens that cause severe infections in poultry, such as Infectious Laryngotracheitis, Mareks Disease and Newcastle Disease.
In Latin America, Innovax vaccines are to be used at the hatchery as a single-dose injection into the egg of 18-day-old embryos (in ovo) or as a subcutaneous injection in the chick at hatch.
"The vaccine range has recently been introduced in Mexico (under the name Fusion) and in Peru and is close to introduction in other Latin American countries. In 2010, we plan to further introduce both Innovax-ILT and Innovax-SB-ND in other parts of the world," said Rick van Oort, global marketing manager of the poultry business unit.
